<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="careful attention and, if necessary, an adaptation of their regular" exact="treatment" post="plans. Fortunately, at present, young people are less suffering"/>
 <result pre="recommended posology [1, 2]. It is considered appropriate to continue" exact="treatment" post="with antihistamine drugs regularly so as not to lose"/>
 <result pre="if necessary, oral corticosteroids (OCS) [2]. The suspension of the" exact="treatment" post="can lead to a condition of poor or lack"/>
 <result pre="maximum of adherence and the â€œpatient engagementâ€� in the regular" exact="treatment" post="and the asthma exacerbations [2, 6â€&quot;9]. Avoid spirometry in"/>
 <result pre="asthma exacerbations [2, 6â€&quot;9]. Avoid spirometry in patients with confirmed/suspected" exact="infection" post="by COVID-19, since the execution of this test can"/>
 <result pre="(disposable filter, instrument sterilization, PPE equipment). Follow the measures of" exact="social distancing" post="and personal hygiene, washing the hands thoroughly, always wearing"/>
 <result pre="wearing PPE, as part of the health activity and rigorous" exact="infection" post="control procedures if aerosol generation procedures are required (for"/>
 <result pre="6â€&quot;9]. It is fundamental to strictly follow the measures of" exact="social distancing" post="and preventive rules, especially when evaluating patients with respiratory"/>
 <result pre="induced by smoking, means increased susceptibility to contract the COVID-19" exact="infection" post="and potentially to develop a more severe form. Food"/>
 <result pre="is not currently known whether the transmission of the SARS-CoV-2" exact="infection" post="is more likely to occur in subjects with active"/>
 <result pre="[30]. Physicians and nurses should not those involved in the" exact="treatment" post="of patients with COVID-19. If there is a drug,"/>
 <result pre="(e.g., biological drugs or anti-cancer therapies) and no alternative for" exact="treatment" post="and the best outcome. So far, hydroxychloroquine, azithromycin, heparin,"/>
 <result pre="is low, and to Remdesivir is unknown [32]. A confident" exact="diagnosis" post="of drug hypersensitivity can be reached by performing a"/>
 <result pre="available to treat any reaction. In those cases, with confirmatory" exact="diagnosis" post="and an absolute indication of treatment, a desensitization protocol"/>
 <result pre="delayed hypersensitivity reactions have been described for macrolides with a" exact="prevalence" post="of 0.07â€&quot;0.7% in children [33]. In the case of"/>
 <result pre="in the injection site, but it has been reported a" exact="prevalence" post="of 3.9% of moderate-severe systemic reactions [31]. Heparins [34],"/>
 <result pre="or respiratory reactions to severe systemic reactions [12]. Latex allergy" exact="prevalence" post="ranges from 1 to 5% in the general population."/>
 <result pre="chronic spontaneous urticaria (CSU) unresponsive to 2nd generation H1-antihistamines, ongoing" exact="treatment" post="with omalizumab should not be discontinued during the COVID-19"/>
 <result pre="monoclonal anti-IgE in the pediatric population, is recommended as a" exact="treatment" post="for children older than 12â€‰years with chronic spontaneous urticaria"/>
 <result pre="to the minor risk of anaphylaxis; then, they can continue" exact="treatment" post="at home [39, 40]. Delaying the beginning of omalizumab"/>
 <result pre="treatment at home [39, 40]. Delaying the beginning of omalizumab" exact="treatment" post="is not suggested as giving long-term high corticosteroid doses"/>
 <result pre="with CSU unresponsive to 2nd generation H1-antihistamines and omalizumab, ongoing" exact="treatment" post="with cyclosporine A should not be stopped during the"/>
 <result pre="adverse effects, cyclosporine A is not recommended as a standard" exact="treatment" post="in CSU. On the other hand, in children and"/>
 <result pre="tract infections [39, 41]. For patients with a new CSU" exact="diagnosis" post="unresponsive to 2nd generation H1-antihistamines and omalizumab, we suggest"/>
 <result pre="and omalizumab, we suggest delaying the beginning of cyclosporine A" exact="treatment" post="consistently with health conditions. Ongoing treatment with immunosuppressive and/or"/>
 <result pre="beginning of cyclosporine A treatment consistently with health conditions. Ongoing" exact="treatment" post="with immunosuppressive and/or biologic agents should be discontinued in"/>
 <result pre="immune response. Whether biologic agents may increase the risk of" exact="infection" post="or cause a severe disease is unknown. Rare allergic"/>
 <result pre="contacts of PID patients. Immunoglobulin replacement therapy represents a life-saving" exact="treatment" post="for many primary immunodeficiencies (PIDs), including hypo/agammaglobulinemia and immunodeficiencies"/>
 <result pre="sufficient if not supported by careful and frequent hand washing," exact="social distancing," post="and other general preventive measures [58, 59, 63]. Protective"/>
 <result pre="administered, is a life-saving drug. Venom immunotherapy is a life-saving" exact="treatment" post="to prevent anaphylaxis, as is effective in 100% of"/>
 <result pre="infected people or even mild, but suggestive symptoms of viral" exact="infection" post="are present. Clinically, these results are manifested in better"/>
 <result pre="in other subjects and the possible worsening of a viral" exact="infection" post="in the patient himself. Immunotherapy (SCIT and SLIT) must"/>
 <result pre="dangerous to continue AIT in individuals with suspected or confirmed" exact="infection" post="with COVID-19 [67]. Moreover, it is useful to avoid"/>
 <result pre="allergic, often present concomitantly and which could delay an adequate" exact="diagnosis" post="and treatment of the COVID-19 infection. Aerobiology and environment"/>
 <result pre="present concomitantly and which could delay an adequate diagnosis and" exact="treatment" post="of the COVID-19 infection. Aerobiology and environment The extensive"/>
 <result pre="Allergology consultation and SPT in children with the specific 2019-nCoV" exact="infection" post="must not be performed. Allergology consultation and SPT in"/>
 <result pre="performed. Allergology consultation and SPT in children with suspected 2019-nCoV" exact="infection" post="(e.g., cough, rhinitis, fever, and epidemiological criteria) must not"/>
 <result pre="nutritionally essential food; suspected drug allergies, in patients who need" exact="treatment" post="with the possible culprit drug (including antibiotics in cystic"/>
 <result pre="the medical staff properly equipped to reduce the risk of" exact="infection" post="for the staff, the child, and the caregiver. In"/>
 <result pre="suspicion thereof immediately upon the appearance of symptoms of COVID-19" exact="infection" post="(or potential symptoms); active and passive cigarette smoking is"/>
 <result pre="[81]. When schools open again, allergic children must be guaranteed:" exact="social distancing," post="washing hands frequently with warm running water with ordinary"/>
 <result pre="immunological and allergological consultations and ensuring the need to keep" exact="social distancing." post="Activating virtual consulting practices by the opportunities offered from"/>
 <result pre="laboratory findings More probable allergic and/or immune-mediated disease Possible alternative" exact="diagnosis" post="Uncontrolled asthma-like symptoms Severe asthma or asthma with comorbidities"/>
 <result pre="symptoms occurring after drug administrationb DRESS, TEN, Stevens-Johnson syndrome viral" exact="infection" post="(EBV, CMV, HHSV6, others), staphylococcal and streptococcal shock syndrome,"/>
 <result pre="Dry or mixed: foreign body, pertussis or parapertussis, or Mycoplasma" exact="infection" post="Pulmonary tuberculosis, tracheobronchomalacia, vascular rings/slings, aspiration syndrome, cystic fibrosis,"/>
 <result pre="disorder Severe neutropenia (9/L) in the context of a pyogenic" exact="infection" post="Severe congenital neutropenia (SCN) Drug-related agranulocytosis, aplastic anemia, autoimmune"/>
 <result pre="and 553 were aged 10 to 19â€‰years) with confirmed SARS-CoV-2" exact="infection" post="were included in the final analysis. All articles reflected"/>
 <result pre="adolescents: a practical update. Allergol Immunopathol. 2020; (in press). 5.CiprandiGCosentinoCMilaneseMMondinoCCanonicaGWFexofenadine" exact="treatment" post="reduces nasal congestion in allergic rhinitisAllergy2001561068107010.1034/j.1398-9995.2001.00191.x11703220 6.Managing childhood allergies"/>
 <result pre="the immune system-working in harmony to reduce the risk of" exact="infection" post="16.MartineauARJoliffeDAGreenbergLAloiaJFBergmanPDubnov-RazGet al.Vitamin D supplementation to prevent acute respiratory infections:"/>
 <result pre="Assess20192314410.3310/hta23020 17.VorilhonPArpajouBVaillant RousselHMerlinEPereiraBCabaillotAEfficacy of vitamin C for the prevention and" exact="treatment" post="of upper respiratory tract infection. A meta-analysis in childrenEur"/>
 <result pre="al. European task force on atopic dermatitis statement on SARS-Cov-2" exact="infection" post="and atopic dermatitis. J Eur Acad Dermatol Venereol. 2020;"/>
 <result pre="2019;144:e20192478. 53.Lu X, Zhang L, Du H, et al. SARS-CoV-2" exact="infection" post="in children. N Engl J Med. 2020. 54.https://ipopi.org/wp-content/uploads/2020/04/COVID19_Joint_StatementUpdate2_ 20200408_"/>
 <result pre="1600CET_FINAL.pdf. Accessed 15 May 2020. 55.BonillaFAKhanDABallasZKChinenJFrankMMHsuJTKellerMet al.Practice parameter for the" exact="diagnosis" post="and management of primary immunodeficiencyJ Allergy Clin Immunol20151361186205.e1â€&quot;7810.1016/j.jaci.2015.04.04926371839 56.Chang"/>
 <result pre="of Exposure and Burden of Disease2016GenevaWorld Health Organization1121 79.Q&amp;amp;A on" exact="infection" post="prevention and control for health care workers caring for"/>
 <result pre="A, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)" exact="infection" post="in children and adolescents: a systematic review. JAMA Pediatr."/>
</results>
